Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
WS04 - IASLC/IMIG Workshop - The Future of Mesothelioma Treatment
- Type: Workshop
- Track: N/A
- Presentations: 8
- Moderators:Kenneth John O'Byrne
- Coordinates: 8/06/2022, 08:00 - 11:00, Lehar 4
-
+
EP05.01 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
- Type: E-Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
- Presentations: 34
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP05.01-011 - Real World Outcomes of Durvalumab after Chemoradiotherapy in unresectable advanced Non-Small Cell Lung Cancer: The Mayo Clinic Experience.
Author(s): Joel Rivera Concepcion- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 171
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.02-037 - Small Cell Transformation in a Patient with RET Fusion Positive Lung Adenocarcinoma on Pralsetinib.
Author(s): Anastasios Dimou- Abstract
Loading...
-
+
P2.14 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
- Type: Regular Poster
- Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
- Presentations: 4
- Coordinates: 8/08/2022, 17:15 - 19:15, Exhibit Hall - Hall B
-
+
P2.14-03 - Restored Ubiquitination and Degradation of Exon 14 Skipped MET with Proteolysis Targeting Chimeras
Author(s): Aaron Scott Mansfield- Abstract
Loading...
-
+
MA13 - Update on ROS1 Inhibitors and New Pathways
- Type: Mini Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 13
- Moderators:Lorenza Landi
- Coordinates: 8/09/2022, 12:00 - 13:00, Hall C7
-
+
MA13.09 - Time from Immune Checkpoint Inhibitor to Sotorasib Use Correlates with Risk of Hepatotoxicity in Non-small Cell Lung Cancer
12:37 - 12:42 | Author(s): Sagar Rakshit
- Abstract
Loading...